Detalles de la búsqueda
1.
Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals.
World J Urol
; 40(2): 409-418, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850270
2.
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Future Oncol
; 16(29): 2307-2328, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964728
3.
Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).
Ann Surg Oncol
; 23(6): 1924-7, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26861905
4.
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial.
BMC Cancer
; 15: 127, 2015 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884155
5.
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Can J Urol
; 19(3): 6261-7, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22704310
6.
Editorial: Immunotherapy in renal cell carcinoma.
Front Oncol
; 12: 945510, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35965584
7.
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib.
BMC Cancer
; 10: 695, 2010 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21194438
8.
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.
ESMO Open
; 5(Suppl 3)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669298
9.
ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.
ESMO Open
; 5(3): e000662, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32393574
10.
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.
Eur J Cancer
; 124: 152-160, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31785463
11.
Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary.
Onkologie
; 32(4): 162-6, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19372710
12.
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040).
J Immunother Cancer
; 7(1): 96, 2019 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30944020
13.
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Nat Med
; 24(12): 1941, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291359
14.
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Nat Med
; 24(6): 749-757, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29867230
15.
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
Eur J Cancer
; 76: 60-67, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28282612
Resultados
1 -
15
de 15
1
Próxima >
>>